Wagstaff J - Search Results

1

Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer.

Honkoop AH, van Diest PJ, de Jong JS, Linn SC, Giaccone G, Hoekman K, Wagstaff J, Pinedo HM. Honkoop AH, et al. Among authors: wagstaff j. Br J Cancer. 1998 Feb;77(4):621-6. doi: 10.1038/bjc.1998.99. Br J Cancer. 1998. PMID: 9484820 Free PMC article.

2

Suramin: rapid loading and weekly maintenance regimens for cancer patients.

van Rijswijk RE, van Loenen AC, Wagstaff J, Meijer E, Lopez R, van Groeningen CJ, Heimans JJ, Pinedo HM. van Rijswijk RE, et al. Among authors: wagstaff j. J Clin Oncol. 1992 Nov;10(11):1788-94. doi: 10.1200/JCO.1992.10.11.1788. J Clin Oncol. 1992. PMID: 1403059

3

Lobular panniculitis after subcutaneous administration of interleukin-2 (IL-2), and its exacerbation during intravenous therapy with IL-2.

Baars JW, Coenen JL, Wagstaff J, van der Valk P, Pinedo HM. Baars JW, et al. Among authors: wagstaff j. Br J Cancer. 1992 Oct;66(4):698-9. doi: 10.1038/bjc.1992.340. Br J Cancer. 1992. PMID: 1419609 Free PMC article.

4

Interleukin-2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia.

Baars JW, de Boer JP, Wagstaff J, Roem D, Eerenberg-Belmer AJ, Nauta J, Pinedo HM, Hack CE. Baars JW, et al. Among authors: wagstaff j. Br J Haematol. 1992 Oct;82(2):295-301. doi: 10.1111/j.1365-2141.1992.tb06421.x. Br J Haematol. 1992. PMID: 1419810

5

Angioneurotic oedema and urticaria during therapy with interleukin-2 (IL-2).

Baars JW, Wagstaff J, Hack CE, Wolbink GJ, Eerenberg-Belmer AJ, Pinedo HM. Baars JW, et al. Among authors: wagstaff j. Ann Oncol. 1992 Mar;3(3):243-4. doi: 10.1093/oxfordjournals.annonc.a058162. Ann Oncol. 1992. PMID: 1586626 Free article. No abstract available.

6

Treatment with tumour infiltrating lymphocytes and interleukin-2 in patients with metastatic melanoma: a pilot study.

Baars JW, Fonk JC, Scheper RJ, von Blomberg-van der Flier BM, Bril H, von Valk P, Pinedo HM, Wagstaff J. Baars JW, et al. Among authors: wagstaff j. Biotherapy. 1992;4(4):289-97. doi: 10.1007/BF02172659. Biotherapy. 1992. PMID: 1622742 Clinical Trial.

7

The effect of schedule, protein binding and growth factors on the activity of suramin.

Lopez Lopez R, Peters GJ, van Loenen AC, Pizao PE, van Rijswijk RE, Wagstaff J, Pinedo HM. Lopez Lopez R, et al. Among authors: wagstaff j. Int J Cancer. 1992 Jul 30;51(6):921-6. doi: 10.1002/ijc.2910510615. Int J Cancer. 1992. PMID: 1639540

8

Reversible thyroid dysfunction during treatment with GM-CSF.

Hoekman K, von Blomberg-van der Flier BM, Wagstaff J, Drexhage HA, Pinedo HM. Hoekman K, et al. Among authors: wagstaff j. Lancet. 1991 Aug 31;338(8766):541-2. doi: 10.1016/0140-6736(91)91103-2. Lancet. 1991. PMID: 1678803

9

The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2.

Baars JW, Hack CE, Wagstaff J, Eerenberg-Belmer AJ, Wolbink GJ, Thijs LG, Strack van Schijndel RJ, van der Vall HL, Pinedo HM. Baars JW, et al. Among authors: wagstaff j. Br J Cancer. 1992 Jan;65(1):96-101. doi: 10.1038/bjc.1992.18. Br J Cancer. 1992. PMID: 1733448 Free PMC article. Clinical Trial.

10

Studies on the contact system of coagulation during therapy with high doses of recombinant IL-2: implications for septic shock.

Hack CE, Wagstaff J, Strack van Schijndel RJ, Eerenberg AJ, Pinedo HM, Thijs LG, Nuijens JH. Hack CE, et al. Among authors: wagstaff j. Thromb Haemost. 1991 May 6;65(5):497-503. Thromb Haemost. 1991. PMID: 1871710

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters